- Home
- OPRA vs OCUL Comparison
OPRA vs OCUL Comparison
Compare OPRA & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OPRA | OCUL |
|---|---|---|
| Founded | 1996 | 2006 |
| Country | Norway | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.9B |
| IPO Year | 2018 | 2014 |
Fundamental Metrics
Financial Performance| Metric | OPRA | OCUL |
|---|---|---|
| Price | $18.14 | $11.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 9 |
| Target Price | $21.50 | ★ $23.56 |
| AVG Volume (30 Days) | 350.6K | ★ 2.6M |
| Earning Date | 04-28-2026 | 05-05-2026 |
| Dividend Yield | ★ 4.61% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,990,000.00 |
| Revenue This Year | $21.29 | $7.93 |
| Revenue Next Year | $15.34 | $96.07 |
| P/E Ratio | $13.62 | ★ N/A |
| Revenue Growth | N/A | ★ 3.48 |
| 52 Week Low | $11.71 | $6.23 |
| 52 Week High | $21.06 | $16.44 |
Technical Indicators
Market Signals| Indicator | OPRA | OCUL |
|---|---|---|
| Relative Strength Index (RSI) | 39.35 | 73.01 |
| Support Level | $18.10 | $11.15 |
| Resistance Level | $19.43 | $12.79 |
| Average True Range (ATR) | 0.61 | 0.46 |
| MACD | -0.18 | 0.31 |
| Stochastic Oscillator | 19.52 | 94.17 |
Price Performance
Historical ComparisonAbout OPRA Opera Limited
Opera Ltd is a consumer internet software company providing a diversified portfolio of high-performance web browsers and adjacent digital services to engaged user base The company has transitioned from browser developer to multi-faceted platform offering a products and services that include PC and mobile browsers, its Opera Gaming portals and development tools, Opera News content platforms, Opera Ads platform, as well as a number of AI and web3 products and services, such as MiniPay and Opera AI, to a user base.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.